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Background and purpose: The Naþ /Ca2þ exchanger (NCX) may play a key role in myocardial contractility. The operation of
the NCX is affected by the action potential (AP) configuration and the intracellular Naþ concentration. This study examined
the effect of selective NCX inhibition by 0.1, 0.3 and 1.0mM SEA0400 on the myocardial contractility in the setting of different
AP configurations and different intracellular Naþ concentrations in rabbit and rat hearts.
Experimental approach: The concentration-dependent effects of SEA0400 on INa/Ca were studied in rat and rabbit ventricular
cardiomyocytes using a patch clamp technique. Starling curves were constructed for isolated, Langendorff-perfused rat and
rabbit hearts. The cardiac sarcolemmal NCX protein densities of both species were compared by immunohistochemistry.
Key results: SEA0400 inhibited INa/Ca with similar efficacy in the two species; there was no difference between the inhibitions
of the forward or reverse mode of the NCX in either species. SEA0400 increased the systolic and the developed pressure in the
rat heart in a concentration-dependent manner, for example, 1.0 mM SEA0400 increased the maximum systolic pressures by
12% relative to the control, whereas it failed to alter the contractility in the rabbit heart. No interspecies difference was found
in the cardiac sarcolemmal NCX protein densities.
Conclusions and implications: NCX inhibition exerted a positive inotropic effect in the rat heart, but it did not influence the
contractility of the rabbit heart. This implies that the AP configuration and the intracellular Naþ concentration may play an
important role in the contractility response to NCX inhibition.
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Keywords: NCX; myocardial contractility; NCX protein density; SEA0400; isolated hearts; EC50
Abbreviations: AP, action potential; ECG, electrocardiogram; Em, transmembrane potential; ICaL, L-type Ca
2þ current; INa,
inward Naþ current; INa/Ca, Na
þ /Ca2þ exchanger current; NCX, Naþ /Ca2þ exchanger
Introduction
The Naþ /Ca2þ exchanger (NCX) is considered to play an
important role in the Ca2þ handling of cardiac myocytes. In
forward mode, the NCX extrudes Ca2þ from the cell,
whereas in reverse mode it brings Ca2þ into the cell from
the extracellular space. The direction of operation of the
NCX depends mainly on the transmembrane gradients of
Ca2þ and Naþ and on the prevailing transmembrane
potential (Em). In the early phase of the action potential,
the NCX works in reverse mode and brings Ca2þ into the
cell, whereas during repolarization, it removes Ca2þ from
the cell in the forward mode. Thus, the duration of the
action potential influences the operation of the NCX (Weber
et al., 2002).
The duration and shape of the action potential may vary
with the species, due to the uneven distribution of the
various transmembrane Kþ channels. For instance, the
duration of the action potential and, particularly, that of
the plateau phase are much longer in rabbit myocytes as
compared with those in rat myocytes, which suggests that
the NCX operates differently in rabbit and rat myocytes.
The cardiac contractility and force development depend
on the free intracellular Ca2þ level and the Ca2þ sensitivity
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of the myofilaments. On a beat-to-beat basis, to increase the
intracellular Ca2þ level, the Ca2þ entry should be increased
or the Ca2þ removal should be decreased. The NCX is
regarded as the main Ca2þ -extruding mechanism in the
heart, and its inhibition may alter the intracellular Ca2þ
level and the cardiac muscle contractility.
A change in the expression (for example, an overexpres-
sion) of the NCX protein can also affect the cardiac muscle
contractility. The overexpression of the NCX in genetically
manipulated feline myocytes caused a decline in contractility
(Weisser-Thomas et al., 2005). The contraction and Ca2þ
transient decreased in NCX-overexpressing rat cardiomyo-
cytes by adenoviral-mediated gene transfer (Bo¨lck et al., 2004).
A weakened cardiac muscle contractility has likewise been
observed in myocardial hypertrophy, heart failure and even
myocardial infarction, due to the increased expression and
altered activity of the NCX (Quinn et al., 2003). However, the
levels of NCX expression in different species under physiolo-
gical conditions have, so far, not been compared. Further-
more, the relationship between the level of NCX expression
and the NCX function has not been elucidated.
A number of benzyloxyphenyl analogues, such as KB-
R7943, YM244769, SN-6 and SEA0400, are known to act as
NCX inhibitors. The IC50 value of SEA0400 for both inward
and outward directions in guinea pig and canine cardio-
myocytes is between 20–300 nM (Tanaka et al., 2002; Birinyi
et al., 2005). SEA0400 is a highly effective inhibitor of the
NCX (Matsuda et al., 2001), with an inhibitory potency 10-
to 100-fold higher than that of KB-R7943 (Takahashi et al.,
2003). The inhibition rate of the forward and the reverse
modes of the NCX with SEA0400 is indeterminate: the drug
caused nearly equivalent inhibition for both modes of NCX
operation in mouse, guinea pig and canine isolated myo-
cardial cells (Tanaka et al., 2002; Nagy et al., 2004; Birinyi
et al., 2005; Namekata et al., 2005; Wang et al., 2007),
whereas it preferentially inhibited the reverse mode in
transfected fibroblasts and in Xenopus laevis oocyte (Iwamoto
et al., 2004; Lee et al., 2004). SEA0400 is considered to be
selective for the NCX up to a concentration of 1.0 mM
without influencing any other ion transport mechanism
(Matsuda et al., 2001; Tanaka et al., 2002; Iwamoto and Kita,
2004). SEA0400 at a concentration of 1.0 mM inhibits 70–80%
of the NCX function (Matsuda et al., 2001; Tanaka et al.,
2002; Birinyi et al., 2005). The concentration-dependent
effects of SEA0400 on NCX current (INa/Ca) have never been
studied in rat and rabbit ventricular cardiomyocytes.
Inhibition of the NCX may affect the contractile function
of the myocardium under pathological conditions, thus it
may have therapeutic implications (Matsuda et al., 2001;
Takahashi et al., 2003). It was recently found that inhibition
of the NCX increased the recovery of the contractile force in
guinea pigs subjected to ischaemia/reperfusion injury
(Namekata et al., 2005). Our group has demonstrated that
NCX inhibition with SEA0400 increases the contractility and
Ca2þ transient in rat isolated myocytes (Acsai et al., 2007).
However, the effects of selective inhibition of the NCX on
the contractility in different species with different action
potential durations under physiological conditions are
currently unknown. Accordingly, our present objective was
to examine the effects of NCX inhibition with SEA0400 on
the cardiac muscle contractility in isolated Langendorff-
perfused hearts in the setting of the long action potential of
the rabbit and in the short action potential of the rat. To
clarify the inhibitory effect of SEA0400 on the reverse and
the forward modes of the NCX in the rabbit and in the rat
isolated myocardial cell, INa/Ca was examined by a patch
clamp technique. NCX protein densities of the two species
were compared to determine whether interspecies differen-
ces in the contractile function can be explained by
differences in NCX expression.
Methods
Animals
New Zealand white rabbits and Sprague–Dawley rats, weigh-
ing 2.3–2.9 kg and 200–250 g, respectively, were used for the
experiments. The animals were handled according to a
protocol reviewed and approved by the Ethical Committee
for the Protection of Animals in Research at the University of
Szeged, Szeged, Hungary.
Isolated, Langendorff-perfused hearts
The anticoagulant sodium heparin was injected into the
marginal ear vein of the rabbits (1000 U) or into
the intraperitoneal space of the rats (250 U). The rabbits
and rats were subsequently stunned by a blow to the neck
and cervical dislocation, respectively. The heart was rapidly
removed via a thoracotomy and rinsed in ice-cold modified
Krebs–Henseleit buffer solution containing (in mM) NaCl
118.5, CaCl2 2.0, glucose 11.1, MgSO4 1.0, NaH2PO4 1.2,
NaHCO3 25 and KCl 4. The aorta was cannulated and hung
on a Langendorff apparatus. The hearts were retrogradely
perfused at a constant temperature of 37 1C with the
modified Krebs–Henseleit buffer solution described above.
A mixture of 95% O2 and 5% CO2 was bubbled through the
buffer, which was equilibrated to pH 7.4. All solutions were
filtered (10 mm pore-size filter) before use. The perfusion
pressure was maintained constant at 80 mm Hg. The volume-
conducted ECG and left ventricular pressure (described later)
were recorded by using National Instruments data acquisi-
tion PC card (National Instruments, Austin, TX, USA) and
SPEL Advanced Haemosys software (version 2.45, Experimetria
Ltd. & Logirex Software Laboratory, Budapest, Hungary).
Coronary flow was measured with a glass flowmeter (Cole-
Parmer Instrument Company, Vernon Hills, IL, USA) posi-
tioned immediately above the retrogradely perfused aorta
and was later corrected for the weight of each heart to give
values in ml min1 g1.
The contractile function of the left ventricle was measured
by using a non-elastic balloon filled with water, connected to
a pressure transducer. The balloon was inserted into the left
ventricle via an incision in the left atrium and the mitral
valve. The ventricular systolic, end-diastolic pressures and
the developed pressure (that is, the systolic pressure minus
the diastolic pressure) were recorded.
SEA0400 concentrations and Langendorff contractility protocol
SEA0400 was chosen for study because of its high specificity
and potency for the NCX. At concentrations up to 3mM,
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SEA0400 has been shown to have no effect on ion currents
other than the NCX (Tanaka et al., 2002). With regard to the
literature and our own measurement of INa/Ca, SEA0400
concentrations of 0.1, 0.3 and 1.0 mM were chosen for the
experiments, as 0.1 and 0.3 mM are around the measured IC50
and SEA0400 is considered selective for the NCX up to a
concentration of 1.0 mM (Figures 1c and d).
A control group (which received the solvent of SEA0400)
and the three treated groups (which received the different
concentrations of SEA0400: 0.1, 0.3 and 1.0 mM) were
compared in both the rabbit heart and the rat heart. Each
of the groups in the rabbit study contained 10 hearts, and
each of the four groups in the rat study contained 12 hearts.
The protocol involved a randomized design with a time-
matched control group, and blind experimentation, data
collation and analysis. The choice of drug solution was made
by reference to a randomization table. Randomization was
achieved by coding each group with a letter whose meaning
was unknown to the operator. Blind analysis was achieved by
using stock solutions prepared by a second operator, who did
not participate in the heart perfusion or data analysis. For
the assessment of the vehicle control or each individual
concentration of the drug, each heart was used only once.
Each heart was set up under Krebs perfusion and the
balloon was inserted into the left ventricle. The ‘zero
volume’ was determined (where the first pressure wave
appeared). The experiment started with a 10 min isovolu-
metric (constant) period, when the balloon was inflated to
an added volume of 0.5 ml in the rabbit heart and of 0.08 ml
in the rat heart, which induced a left ventricular pressure
that was approximately 60% of the maximum developed
pressure. Next, commencing from ‘zero volume’, 0.1 ml
increments in the rabbit heart and 0.02 ml increments in
the rat heart were added to the balloon volume every minute
to reach the maximum developed pressure (a Starling curve
was constructed), the final diastolic pressure not being
allowed to exceed 10 mm Hg. This was followed by another
5 min isovolumetric period and the whole procedure was
repeated in the presence of the test drug.
Individual measurements of coronary flow, left ventricle
pressure and ECG variables were made 1 min before, 4 min
after and every minute during the Starling curves. This made
Figure 1 Concentration-dependent effects of SEA0400. Superimposed current traces obtained in Kþ -free bath solution (control), in the
presence of 1.0 mM SEA0400 and after addition of 10 mM NiCl2 to block completely INa/Ca in the rabbit (a) and the rat (b) myocyte. Outward
and inward INa/Ca were determined during the descending limb of the ramp at þ40 and 80 mV. Concentration-dependent blocking effect of
SEA0400 on forward INa/Ca and reverse INa/Ca in rabbit (c) and in rat (d) myocytes. The solid line was obtained by fitting data to the Hill
equation. Four cells were challenged in every examined concentrations of SEA0400. Symbols and bars represent mean±s.e.mean.
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it possible to evaluate the immediate effects of the drug on
the heart function under both isovolumetric and non-
isovolumetric conditions. The constant balloon volume
inflation applied (0.5 and 0.08 ml in the rabbit heart and
the rat heart, respectively), which had been shown to give
rise to approximately 60% maximum pressure development,
was appropriate for the assessment of either positive or
negative effects of the test drug on the ventricular function.
The first Starling curve was constructed to test the health of
each heart and to provide drug-free baseline data. The two
Starling curves (before and during drug perfusion) were used
to evaluate the inotropic and lusitropic effects completely. At
the end of each experiment, the atria were removed from the
heart and the ventricles were weighed. The protocol is
outlined in Figure 2.
Exclusion criteria
Any heart with a coronary flow less than 5 ml min1 g1, or
those with an impaired contractility function observed in
the first Starling curve or those not in a constant sinus
rhythm were excluded. Excluded hearts were replaced to
maintain equal group sizes.
Coronary flow measurement and ECG analysis
Coronary flow and ECG intervals were measured at pre-
determined time points. Coronary flow values were read
directly from the flowmeter during the experiment. After
completion of the experiments, the data were replayed and
the PQ, QRS, QT and RR intervals were measured by manual
positioning of on-screen markers. The QT interval was
defined as the time between the first deviation from the
isoelectric line during the PQ interval until the end of the TU
wave. In the rabbit hearts, where the T or U wave overlapped
the following P wave or the QRS complex of the subsequent
sinus beat, the extrapolation method was used to measure
the length of the QT (or QU) interval (Farkas et al., 2004).
Isolation of cardiac myocytes
Rabbits and rats (see above) were used for the isolation of
myocytes, and the hearts were prepared as described above.
Briefly, the hearts were excised and Langendorff-perfused. A
modified Krebs–Henseleit buffer solution containing (in mM)
NaCl 118.5, KCl 4, MgSO4 1.0, NaH2PO4 1.2, NaHCO3 25 and
glucose 11.1 at pH 7.4 was used as the perfusate for the rat
hearts, and a modified Tyrode buffer solution containing (in
mM) NaCl 130, HEPES 23, taurin 20, creatine 5, MgCl2 5, Na-
pyruvate 5, KCl 4.5, NaH2PO4 1 and glucose 21 at pH 7.3 was
used as the perfusate for the rabbit hearts. In the first 5 min,
additional CaCl2 (2 mM for the rat heart and 1 mM for the
rabbit heart) was added to the buffer, and this was followed
by a 5 min Ca2þ -free period. In the next step, collagenase,
hyaluronidase and CaCl2 (200 mM) were added to the buffer
for the rats, whereas collagenase, protease and CaCl2
(100 mM) were added to the buffer for the rabbits, and the
hearts were perfused for an additional 10 min. The left
ventricular myocardium was then minced and gently
agitated. Isolated cells were stored in KB solution, containing
(in mM) KOH 89, glutamic acid 70, taurin 15, KCl 30,
KH2PO4 10, HEPES 10, MgCl2 0.5, glucose 11 and EGTA 0.5,
the pH being titrated to 7.3 with KOH, at room temperature.
Measurement of INa/Ca
To examine the effects of SEA0400 on the NCX current, the
whole-cell configuration of the patch clamp technique was
applied (Birinyi et al., 2005). After establishment of the
whole-cell configuration in Tyrode solution, the cell was
superfused with a special Kþ -free bath solution containing
(in mM) NaCl 135, CsCl 10, CaCl2 1, MgCl2 1, BaCl2 0.2,
NaH2PO4 0.33, TEACl 10, HEPES 10, glucose 10, pH 7.4,
supplemented with 20 mM ouabain, 1mM nisoldipine and
50 mM lidocaine to block Naþ , Kþ , Ca2þ and Na/K pump
currents. The pipette solution contained (in mM) CsOH 140,
aspartic acid 75, TEACl 20, Mg-ATP 5, HEPES 10, NaCl 20,
EGTA 20, CaCl2 10, pH 7.2. The Ca
2þ concentration was
estimated to be approximately 160 nM in this pipette
solution. INa/Ca was recorded by using ramp pulses (having
a velocity of 100 mV s1) delivered at a rate of 0.05 Hz. The
membrane was initially depolarized from the holding
potential of 40 mV to þ 60 mV, then hyperpolarized to
100 mV, and finally the membrane potential returned to
the holding potential. The outward and the inward INa/Ca
were determined during the descending limb of the ramp, at
Figure 2 The protocol applied in isolated, Langendorff-perfused hearts: in the first half of the experiment, all the hearts were perfused with
Krebs buffer; the perfusion solution was then switched to the test drug in the second half of the experiment. (a) Protocol for rabbit hearts. (b)
Protocol for rat hearts. Exp. time, experimental time; balloon V, volume of the left ventricular balloon; Starling curve, starting from the ‘zero
volume’ 0.1 ml increments for the rabbit heart and 0.02 ml increments for the rat heart were added to the balloon volume every minute.
NCX inhibition and myocardial contractility
AS Farkas et al96
British Journal of Pharmacology (2008) 154 93–104
þ40 and –80 mV, respectively. After the control recording in
Kþ -free solution, the cell was superfused with the given
concentration of SEA0400 and finally 10 mM NiCl2 was
added to block INa/Ca completely. Thus, total INa/Ca was
determined at both membrane potentials as a Ni2þ -sensitive
current by subtracting the third record from the first. The
fraction of the blockade induced by SEA0400 was expressed
as a percentage of the total INa/Ca.
Immunohistochemistry
Rabbit and rat isolated cardiomyocytes from the left ventricle
were fixed with acetone. Before staining, the samples were
rehydrated in Ca2þ -free phosphate-buffered saline and
blocked for 120 min at room temperature with phosphate-
buffered saline with 0.01% Tween containing 1% bovine
serum albumin. Indirect immunofluorescence staining was
carried out by using mouse anti-NCX primary antibody in a
dilution of 1:1000 and with a fluorescent secondary antibody
conjugated goat anti-mouse IgG in a dilution of 1:1000. An
incubation period of 60 min with the primary antibody at
room temperature was followed by a 60 min incubation with
the secondary antibody. Between and after the incubations,
the samples were washed thoroughly with phosphate-
buffered saline with 0.01% Tween. Control samples were
incubated only with the secondary antibody. For microscopic
examination, the cells were mounted in Aqua PolyMount.
Confocal laser scanning microscopy and quantification of
fluorescence intensities
Confocal laser scanning microscopy was applied for the
quantification of the NCX on the sarcolemmal surface of
cardiac myocyte (Sepre´nyi et al., 2006). This method of
semiquantitative confocal image analysis can reliably distin-
guish 10–15% difference.
Serial images of the immunostained samples were captured
by means of an Olympus FV1000 confocal laser scanning
microscope (Olympus Co., Tokyo, Japan) with standard
parameter settings. For quantitative analysis, the pictures
were converted to greyscale TIFF file format with Adobe
Photoshop software (Adobe Systems Inc., San Jose, CA, USA).
The immunofluorescence of the cardiac muscle cells was
quantitatively analysed with ImageQuant software (Molecu-
lar Dynamics, Sunnyvale, CA, USA) as follows: first the
background was eliminated with the threshold set-up. The
fluorescent images of 25 randomly selected rat and 25 rabbit
cardiac myocytes, in each case derived from four animals,
were subjected to immunofluorescent profile analysis: in
each image, 2–5 random bands were selected and their
fluorescent profiles were plotted in the profile plots, and the
baseline pixels were identified and subtracted from the total
profile area. In this way, the actual fluorescent pixel
intensities were obtained from the specific staining. The
average values and the standard error of the fluorescent
intensity per pixel were calculated.
Drugs and materials
Perfusion solutions were prepared fresh each day. The
‘vehicle stock’ was a 7 ml solution of DMSO (Sigma-Aldrich
Inc., St Louis, MO, USA). The ‘1.0 mM SEA0400 stock’
was prepared from 30.58 mg of SEA0400 dissolved in 3.0 ml
of DMSO. The ‘0.3 mM SEA0400’ solution was prepared by
mixing 0.6 ml of ‘1.0mM SEA0400 stock’ and 1.4 ml
of ‘vehicle stock’. The ‘0.1 mM SEA0400 stock’ was prepared
by mixing 0.2 ml of ‘1.0 mM SEA0400 stock’ and 1.8 ml of
‘vehicle stock’. A quantity of 0.1 ml of the chosen stock
dissolved in 2.5 l of modified Krebs–Henseleit buffer yielded
the appropriate solution.
Drugs were purchased from the following sources:
collagenase (0.05%, type 1A) from Worthington Biochemical
Corporation (Lakewood, NJ, USA); NCX antibody from
Novus Biologicals Inc. (Littleton, CO, USA); fluorescent
secondary antibody conjugated goat antimouse IgG from
Molecular Probe, Invitrogen Co. (Carlsbad, California, USA);
Aqua PolyMount from Polysciences Inc. (Warrington, PA,
USA). Other drugs for the isolation of myocytes were from
Sigma-Aldrich Inc. (St Louis, MO, USA).
All other salts were purchased from Molar Chemical Ltd.
(Budapest, Hungary). Water for the preparation of perfusion
solutions was obtained from a reverse osmosis system (Milli-Q
RG, Millipore Ltd., Billerca, MA, USA) fed by distilled water
and had a specific resistivity of 418 MO.
The synthesis of 2-(4-((2,5-difluorophenyl)methoxy)phe-
noxy)-5-ethoxy-aniline (SEA0400) was performed by Ferenc
Fu¨lo¨p (Department of Pharmaceutical Chemistry, University
of Szeged, Szeged, Hungary) according to a method described
in the literature (Aibe et al., 2000). The product was isolated
as hydrochloride salt. Melting point¼172–174 1C (recrystal-
lized from ethanol-ether). 1H-NMR (400 MHz, DMSO) d¼1.3
(t, 3H, CH3), 3.93–3.98 (m, 2H, OCH2), 5.09 (s, 2H, OCH2),
6.49–6.51 (m, 1H, Ar-H), 6.73–6.76 (m, 2H, Ar-H), 6.92–6.94
(d, 2H, Ar-H), 7.02–7.04 (d, 2H, Ar-H), 7.25–7.4 (m, 3H, Ar-H).
Statistical evaluation
Continuous data were expressed as means±s.e.mean. When
drug effects were analysed, continuous data from indepen-
dent samples were subjected to repeated measures analysis of
variance, whereas NCX protein density data from indepen-
dent samples were compared through one-way analysis of
variance. Po0.05 was taken as indicative of a statistically
significant difference between values.
Results
Effects of SEA0400 on INa/Ca in isolated myocytes
INa/Ca was recorded as a Ni
2þ -sensitive current using the
descending limb of a ramp pulse changing slowly from þ60
to 100 mV during 1.6 s. The outward and the inward INa/Ca
were determined at þ 40 and –80 mV, respectively (Figures 1a
and b).
Rabbit. SEA0400 suppressed both the inward and the
outward INa/Ca, that is, the Ni
2þ -sensitive current was
significantly decreased by these compounds in a concentra-
tion-dependent manner (Figure 1c). IC50 values of the
inward (forward) and the outward (reverse) currents were
243 and 309 nM, respectively. Data were fitted to the Hill
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equation. As full inhibition of INa/Ca was not achieved under
our experimental conditions, drug concentrations causing
50% reduction of the currents were higher than the
respective EC50 values. No significant difference was seen
in the SEA0400-induced suppression of the inward and the
outward INa/Ca (Figure 1c).
Rat. IC50 values of the inward (forward) and the outward
(reverse) currents were 120 and 61 nM in rat myocytes,
respectively (Figure 1d). SEA0400 blocked INa/Ca by 70% at a
concentration of 1mM. No significant difference was found
between the inhibitions of the two modes of NCX.
Systolic, end-diastolic and developed pressures
Rabbit. During the first Starling curve and at a constant
balloon volume (Krebs solution), the applied balloon stretch
increased the systolic and developed pressures very similarly
in all four groups, whereas the diastolic pressures did not
exceed 10 mm Hg even at maximum balloon inflation
(1.5 ml), proving that the hearts were not overstretched.
The SEA0400 concentrations applied (0.1, 0.3 and 1.0 mM)
failed to alter the systolic and developed pressures at the
constant balloon volume and in the second Starling curve as
compared with the control group (Table 1a). When the
systolic pressures measured at the maximum balloon volume
of the second Starling curve were divided by the correspond-
ing values of the drug-free first Starling curve, a concentra-
tion-dependent, but slight and insignificant, positive
inotropic effect of SEA0400 was revealed (Figures 3a
and 4a). A similar tendency was observed in the correspond-
ing values of the developed pressure (Table 1a). The diastolic
pressure was not changed significantly during the second
Starling curve and the developed pressure did not differ
between the groups during perfusion with SEA0400
(Table 1a).
Rat. Following the striking resemblance between the four
groups in the drug-free first Starling curve, the applied
SEA0400 concentrations increased the systolic pressure in a
concentration-dependent manner both at a constant balloon
volume and during the second Starling curve. The 1.0 mM
SEA0400 group differed significantly from the control
(Table 1b, Figure 4b). A significant and concentration-
dependent positive effect of SEA0400 was also revealed when
the systolic pressures measured at the maximum balloon
volume of the second Starling curve were divided by the
corresponding values of the drug-free first Starling curve
(Figure 3b). The developed pressure also increased in a
concentration-dependent manner during perfusion with
SEA0400, as the systolic pressure increased, whereas the
diastolic pressure remained unchanged (Table 1b).
ECG intervals and heart rate
The ECG intervals were almost constant during both Starling
curves in both species. Perfusion with SEA0400 did not
influence the PQ, QRS and QT intervals in either species
(Table 2). The increased left ventricle stretch did not affect
the ECG intervals; no differences were found between the
constant and alternating balloon volume periods. SEA0400
perfusion did not exert any effect on the heart rate in either
species. The corresponding ECG intervals of the SEA0400-
perfused groups of hearts did not differ from those for the
control group in either the rabbit or the rat study (Table 2).
Coronary flow
The coronary artery flow was measured during both
isovolumetric and increasing stretch periods in the absence
and presence of SEA0400. The increasing left ventricular
stretch induced by the balloon inflation caused a slight flow
elevation in every group of both species. The mean coronary
flow ranged from 6.8±0.7 to 9±0.9 ml min1 g1 and from
7.9±0.3 to 12.5±1.2 ml min1 g1 in the rabbit heart and in
the rat heart, respectively. There was no significant differ-
ence between the flow values of the various groups at any
time point of the experiments in either species.
NCX protein density
Immunohistochemistry was performed to characterize the
NCX protein density of the plasma membrane in the rabbit
and rat isolated myocytes. Immunohistochemistry with
confocal microscopy imaging revealed similar scattered
distributions of the NCX protein on the surface of the rabbit
and the rat myocytes. The physiological cardiac sarcolemmal
NCX protein density did not differ in the rabbit and the rat
(Figure 5).
Discussion
Our results demonstrate that selective inhibition of the NCX
by SEA0400, which is considered to be a selective inhibitor of
the NCX (Matsuda et al., 2001; Tanaka et al., 2002; Iwamoto
and Kita, 2004), did not considerably influence the contrac-
tility in the rabbit isolated heart, whereas it increased the
systolic and developed pressures in a concentration-depen-
dent manner in the rat isolated heart. The NCX inhibition
with the selective inhibitor SEA0400 was almost identical in
the rabbit and rat myocytes, when the highest concentration
of the drug was used, which significantly increased the
contractile force in rats. The immunohistochemistry did not
indicate a significant difference between the sarcolemmal
NCX protein densities of the rabbit and the rat. Furthermore,
heart perfusion with the NCX inhibitor SEA0400 did not
influence the ECG intervals (PQ, QRS, QT and RR) or the
coronary flow, the latter revealing that the drug did not
affect the cardiac vessels either.
Pharmacodynamic effects of SEA0400
SEA0400 up to a concentration of 3.0mM is considered to
be selective for the NCX without influencing any other
ion transport mechanism (Tanaka et al., 2002), although
Birinyi et al. (2005) found that SEA0400 at a concentration of
1.0 mM inhibited the L-type Ca2þ current (ICaL) in canine
myocytes, which may explain the lack of positive contrac-
tility response in the rabbit heart. Recently, we found
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in patch clamped rat myocytes that SEA0400-induced
increase in the Ca2þ transient and cell shortening was
accompanied by significant reduction of ICaL (Acsai et al.,
2007). These effects can be explained by the autoregulatory
nature of cardiac Ca2þ handling, as the reduced Ca2þ efflux
from the cell results in an increased Ca2þ load to the
sarcoplasmic reticulum leading to increased Ca2þ release,
which in turn may decrease the ICaL by acceleration of Ca
2þ -
dependent inactivation of ICaL (Acsai et al., 2007). Nagy et al.
(2004) reported that SEA0400 at a concentration of 1.0 mM
failed to change ICaL significantly in canine myocytes.
Similarly, our data did not reveal any effect of SEA0400 on
the ECG PQ intervals, which would have been widened if
ICaL had been blocked by the drug (Farkas et al., 1999).
Nevertheless, SEA0400 inhibited Ca2þ transients in heart
tubes from NCX1 knockout mice, arguing against strict
selectivity of the drug for NCX1 (Reuter et al., 2002). In the
current study, the lack of any effect of SEA0400 on the
coronary flow, the heart rate and the ECG intervals implies
that the observed difference in contractility of the rat and
rabbit heart caused by NCX inhibition with SEA0400 was not
related to any effect of the drug on the coronary flow or the
Table 1 Systolic, diastolic and developed pressures in the presence of SEA0400 in the rabbit heart (a) and the rat heart (b)
Balloon V (ml) 0.5 0.1 0.3 0.5 0.7 0.9 1.1 1.3 1.5 0.5
SEA0400
(a) Rabbit
Systolic P (mm Hg)
Control 100±9 78±7 89±7 98±9 106±10 114±10 122±10 128±10 128±12 84±10
0.1 (mm) 98±7 77±10 88±9 95±7 102±7 109±6 116±7 124±7 134±7 94±6
0.3 (mm) 92±9 70±11 81±10 90±10 101±10 109±9 120±11 126±9 129±8 78±15
1.0 (mm) 111±7 91±7 97±7 106±7 114±7 120±4 129±8 136±8 141±7 100±6
Diastolic P (mm Hg)
Control 1.3±0.6 3.2±1.3 0.6±0.7 1.6±0.7 2.8±0.7 3.7±0.7 4.5±0.9 5.5±0.9 6.0±1.4 0.9±0.6
0.1 (mm) 0.6±0.4 2.8±0.8 1.2±0.5 1.2±0.4 1.9±0.4 2.4±0.5 3.1±0.6 4.1±0.9 5.5±1.2 0.9±0.5
0.3 (mm) 0.9±0.6 2.9±0.6 0.1±0.6 1.1±0.6 2.6±0.5 3.8±0.8 4.1±0.7 4.0±0.8 4.9±1.0 1.7±0.7
1.0 (mm) 1.7±0.4 2.5±0.4 0.9±0.4 1.7±0.4 2.4±0.4 3.5±0.5 4.7±0.6 5.8±0.9 6.9±1.3 1.4±0.4
Developed P (mm Hg)
Control 99±9 81±7 89±7 96±9 103±10 110±10 117±10 122±9 122±11 83±10
0.1 (mm) 98±6 79±9 89±8 94±6 100±6 106±6 113±6 120±6 129±7 94±6
0.3 (mm) 91±9 73±11 91±10 89±9 98±9 105±9 115±11 122±8 108±17 76±14
1.0 (mm) 109±6 93±7 96±7 104±6 111±7 117±7 125±7 131±8 134±7 99±6
0.08 0.02 0.04 0.06 0.08 0.10 0.12 0.14 0.16 0.18 0.08
Balloon V (ml) 0.5 0.1 0.3 0.5 0.7 0.9 1.1 1.3 1.5 0.5
(b) Rat
Systolic P (mm Hg)
Control 77±3 35±3 53±2 68±3 83±3 97±3 109±3 118±3 127±3 135±4 70±3
0.1 (mm) 85±3 33±3 58±3 74±3 91±3 103±3 112±4 124±4 127±6 138±5 80±4
0.3 (mm) 84±4 38±4 60±4 77±4 91±4 104±4 115±3 125±4 134±3 146±4 84±5
1.0 (mm) 90±4* 38±2* 64±3* 84±4* 100±5* 115±6* 126±6* 136±7* 146±7* 153±8* 99±6*
Diastolic P (mm Hg)
Control 0.1±0.6 8.3±0.9 2.4±0.7 0.8±0.6 0.4±0.6 1.3±0.6 2.1±0.6 3.4±0.6 4.8±0.5 6.7±0.5 0.5±0.6
0.1 (mm) 0.1±0.6 10.9±1.2 2.2±0.7 0.6±0.6 0.8±0.7 1.4±0.7 2.5±0.8 4.1±0.9 3.9±0.7 6.0±1.1 0.3±0.6
0.3 (mm) 0.1±0.3 8.7±0.6 2.3±0.2 0.5±0.2 0.8±0.3 1.8±0.3 2.4±0.4 3.0±0.3 4.0±0.3 5.4±0.4 0.1±0.3
1.0 (mm) 0.6±0.3 11.2±0.6 2.3±0.3 0.0±0.4 1.2±0.4 2.4±0.5 3.2±0.6 4.3±0.9 6.0±1.0 5.8±0.7 0.6±0.4
Developed P (mm Hg)
Control 77±3 43±3 55±2 59±3 82±4 96±4 107±4 115±4 122±3 129±4 70±3
0.1 (mm) 85±3 43±2 61±3 74±3 91±3 102±3 110±3 120±4 123±6 132±5 80±4
0.3 (mm) 84±4 47±4 62±4 77±4 90±4 102±4 113±3 122±4 130±3 141±3 84±5
1.0 (mm) 89±4* 50±2* 66±3* 84±4* 99±4* 112±6* 123±6* 132±6* 140±6* 147±8* 99±6*
Abbreviations: Balloon V, volume of the left ventricular balloon; developed P, developed pressure (systolic minus end-diastolic pressure); diastolic P, left ventricular
diastolic pressure; systolic P, left ventricular systolic pressure.
*Po0.05 vs control.
Figure 3 Systolic pressure ratios of the maximum balloon volume
of the second (drug-perfused) and the first (drug-free) Starling
curves in rabbit heart (a) and in the rat heart (b). Values are means
and vertical lines show s.e.mean. *Po0.05 vs control.
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sarcolemmal ion channel functions reflected by the ECG
intervals.
In a recent study, Tanaka et al. (2002) measured slightly
lower EC50 (IC50) values (40 and 32 nM for the inward and
the outward NCX current, respectively) of the SEA0400 for
the NCX in guinea pig myocytes as compared with those we
measured in rat and rabbit isolated myocytes. Either the
different species or the different experimental circumstances
may explain this difference between the results of this and
earlier studies. In this study, we found that SEA0400 had a
slightly but non-significantly greater affinity to NCX in the
rat than in the rabbit, although the maximum inhibition
(specific activity) was almost equivalent (B70%) in both
species. Nevertheless, a significant contractile elevating
effect of SEA0400 was only found at a concentration of
1.0 mM when the NCX block was almost maximal in both
species. This indicates that the slight difference in the
affinity of the drug for the rat or rabbit NCX is not the
main reason for the species-dependent contractile force
difference in this study.
There are several reports where SEA0400 exerted a greater
degree of inhibition for reverse currents than for forward
currents in transfected fibroblasts and in mutant X. laevis
oocytes (Bouchard et al., 2004; Iwamoto and Kita, 2004;
Lee et al., 2004), similar to other NCX benzyloxyphenyl
derivative inhibitors, such as KB-R7943 and SN-6 (Iwamoto
and Kita, 2004). However, in this study, SEA0400
(0.03–3.0 mM) inhibited both the forward and the reverse
modes of the NCX operation, with similar efficacy, either in
rabbit or rat isolated myocytes. These results corroborate the
previous findings on mouse, guinea pig and canine isolated
myocardial cells and neuronal cells (Matsuda et al., 2001;
Tanaka et al., 2002; Birinyi et al., 2005; Namekata et al., 2005;
Wang et al., 2007). Accordingly, the potency of SEA0400 for
the two modes of NCX varies depending upon experimental
conditions. These data suggest that different experimental
models reveal different SEA0400 effects on NCX, and in non-
manipulated isolated myocytes, SEA0400 similarly inhibits
both inward and outward INa/Ca in these mammalian species.
The effect of NCX on contractility is determined by
species-dependent and pathological factors
SEA0400 1.0 mM was found to increase the contractile force,
the cell shortening and the Ca2þ transient amplitude in an
isolated ventricular tissue preparation of the mouse, which
possesses a very short action potential duration (Tanaka
et al., 2005). In a recent study with rat isolated myocytes, the
amplitude of the intracellular Ca2þ transient and cell
shortening was significantly increased by SEA0400 in field-
stimulated and voltage-clamped myocytes (Acsai et al.,
2007). These results are consistent with our whole rat heart
contractile force results. In contrast, in the guinea pig
myocardium, which exhibits a longer action potential
duration, 1.0 mM SEA0400 increased the contractile force by
only 5% (Tanaka et al., 2007). SEA0400 at a concentration of
1.0 mM significantly decreased the ouabain-induced inotropy
when the reverse mode of NCX operation was favoured due
to the high intracellular Naþ (Nai) level in the guinea pig
myocardium (Tanaka et al., 2007). SEA0400 1.0 mM did not
affect the contractile force or the contractile force decay
under normal conditions in guinea pig myocardium, but it
significantly enhanced the recovery of the contractile force
in ischaemia/reperfusion (Namekata et al., 2005). This is
supported by our findings in the healthy rabbit heart, which
has a longer action potential duration, as 1.0 mM SEA0400 did
not elevate the contractile force significantly. In myocardial
stunning in anaesthetized dogs, SEA0400 had no direct effect
Figure 4 Starling curves, that is, systolic pressures plotted vs balloon volume, in the rabbit heart (a) and the rat heart (b). In the first half of the
experiment, all the hearts were perfused with Krebs buffer (first Starling curve); the perfusion solution was then switched to the test drug in the
second half of the experiment (second Starling curve). Between the two Starling curves, an isovolumetric period was applied in the presence of
the drug (see Figure 1 for the protocol). Control and 1.0 mM SEA0400 concentration values are presented as means with vertical lines showing
s.e.mean. *Po0.05 vs control.
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on contractility (Takahashi et al., 2004). However, 1.0 mM
SEA0400 significantly improved the recovery of the post-
ischaemic left ventricle pressure in the rabbit heart (Magee
et al., 2003) and in the rat heart (Takahashi et al., 2003). This
SEA0400 concentration likewise increased the contraction in
rat hearts with a short action potential duration in our study,
although under physiological conditions.
The above-mentioned findings emphasize the importance
of different species-dependent and pathological factors of
NCX functioning. The results imply that, under physiologi-
cal conditions, NCX inhibition increases the contractility
only in species that possess a short action potential duration;
under pathological conditions, NCX inhibition may increase
the contractile force even in species with a longer action
potential duration.
Species-dependent relationship between the NCX function and
contractility: possible mechanisms
The direction of operation of the NCX depends on (i) the
intracellular and the extracellular Ca2þ and Naþ concentra-
tions, (ii) the prevailing phase and the shape of the action
potential, and (iii) the pH (Blaustein and Lederer, 1999).
Physiologically, the intracellular pH does not differ con-
siderably in the rat heart and the rabbit heart. In contrast,
the rabbit and the rat differ in some functional properties
(for example, action potential and intracellular Naþ ) as
concerns the operation of the NCX (Bers, 2001). The action
potential duration of the rat (30–60 ms) is much shorter than
that of the rabbit (150–200 ms) (Szigligeti et al., 1996). The
actual membrane potential (Em) and the reversal potential of
the NCX (ENa/Ca) define the direction of operation of the
Table 2 The electrocardiographic PQ, QRS, QT intervals and the heart rate in the presence of SEA0400 in rabbit heart (a) and in rat heart (b)




Control 61±1 58±2 59±2 60±2 62±3 60±2 59±2 59±3 60±3 57±2
0.1 (mm) 68±3 67±3 67±4 66±3 68±3 67±4 67±4 67±4 69±4 68±4
0.3 (mm) 63±3 61±3 60±3 62±3 61±3 62±3 61±3 60±4 55±2 60±3
1.0 (mm) 64±4 67±5 66±4 67±4 65±4 64±3 61±4 64±3 63±3 64±3
QRS (ms)
Control 60±2 60±2 59±2 59±3 60±3 62±3 63±3 64±3 67±3 61±5
0.1 (mm) 60±3 60±3 59±3 57±3 61±3 62±2 60±3 61±3 62±3 59±4
0.3 (mm) 67±4 66±4 60±4 64±6 63±5 64±4 67±5 65±4 67±5 66±3
1.0 (mm) 67±3 66±3 66±4 65±4 65±2 64±2 67±2 66±3 68±3 65±2
QT (ms)
Control 201±7 199±6 200±6 201±7 200±7 200±6 198±6 199±8 194±9 205±8
0.1 (mm) 214±9 213±8 212±8 214±8 210±9 207±8 206±9 207±5 208±8 209±10
0.3 (mm) 211±9 205±10 206±9 216±15 109±15 204±6 204±7 199±6 211±11 202±9
1.0 (mm) 209±4 210±4 207±7 206±7 204±7 199±7 199±8 198±8 201±7 207±6
HR (min1)
Control 186±8 187±9 187±8 187±8 186±8 187±8 185±8 187±9 188±10 175±8
0.1 (mm) 169±12 171±11 171±12 169±11 191±12 180±12 179±11 173±12 173±12 173±12
0.3 (mm) 184±13 186±12 187±12 185±13 186±12 186±12 186±11 183±11 175±13 190±14
1.0 (mm) 173±7 173±7 174±7 174±7 175±7 1175±7 175±7 175±8 174±8 174±8
0.08 0.02 0.04 0.06 0.08 0.10 0.12 0.14 0.16 0.18 0.08
Balloon V (ml) 0.5 0.1 0.3 0.5 0.7 0.9 1.1 1.3 1.5 0.5
(b) rat
PQ (ms)
Control 46±2 46±2 46±3 45±3 46±3 46±2 43±3 45±3 45±3 48±2 43±3
0.1 (mm) 45±2 45±2 47±2 44±2 44±2 44±2 46±2 45±2 44±2 47±2 43±2
0.3 (mm) 49±2 49±3 45±3 47±3 47±3 48±3 49±3 48±3 48±3 50±3 49±3
1.0 (mm) 47±3 49±3 47±3 48±3 48±3 49±3 48±3 47±2 46±2 47±3 48±3
QT (ms)
Control 98±3 95±3 97±3 96±3 96±4 96±3 95±4 96±4 95±4 96±4 98±3
0.1 (mm) 99±4 95±5 97±4 96±4 96±4 98±4 99±4 100±4 98±4 100±4 97±3
0.3 (mm) 84±3 88±3 90±2 92±4 89±3 92±4 91±4 92±3 94±4 90±2 88±3
1.0 (mm) 89±4 89±4 92±3 91±4 91±3 91±4 90±2 91±3 92±3 92±4 92±3
HR (min1)
Control 290±7 294±8 292±8 290±8 289±6 290±7 291±6 288±6 287±7 285±9 287±7
0.1 (mm) 290±10 290±10 290±10 287±10 286±9 285±9 286±9 283±8 274±10 275±13 282±10
0.3 (mm) 287±13 289±12 289±12 288±12 283±12 285±12 285±12 287±12 285±11 283±11 284±12
1.0 (mm) 289±6 289±6 287±6 289±7 288±7 289±7 292±7 285±8 286±8 286±10 291±7
Abbreviations: Balloon V, volume of the left ventricular balloon; HR, heart rate.
QRS interval was not measured in rat hearts, as the QRS and the QT interval is merged in the rat ECG.
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NCX: the reversal potential depends on the Nai which is
higher in the rat (12.7–16.0 mM) than in the rabbit
(7.2–9.0 mM) (Bers, 2001). During depolarization, Em is more
positive than ENa/Ca, which favours the reverse mode (Ca
2þ
influx). When Em becomes more negative, the NCX operates
in the forward mode (Ca2þefflux). Because of the shorter
action potential and higher Nai in rats, the NCX operates
mainly in forward mode, even in systole (Bers, 2001), and
the functional role of Ca2þ extrusion through the forward
mode of the NCX is larger in species with a shorter action
potential duration (Tanaka et al., 2007). The longer action
potential duration of the rabbit allows the NCX to operate in
the reverse mode for a longer duration as compared with that
in the rat. Accordingly, inhibition of the NCX operation in
the settings of a short action potential in the mouse or the
rat mainly affects the Ca2þ efflux (forward mode), which
may result in intracellular Ca2þ accumulation on a beat-to-
beat basis in the cardiac cycle under physiological condi-
tions, thereby leading to an increased contractile force. In
contrast, contractility fails to increase significantly in species
with the settings of a longer action potential (for example,
guinea pig, rabbit and dog). Our rat and rabbit heart
contractility results support this hypothesis. Despa and Bers
found that NCX blocking Ni2þ reduced resting Naþ influx
by almost 40% in rat (Despa et al., 2002), which may
underline the important role of the NCX in the Ca2þ
extrusion in rats.
However, there are some experimental data that do not
support this explanation. Weber et al. observed that during
the depolarization phase of the action potential, the reverse
mode of the NCX may bring Ca2þ into the cell only up to
15 ms in the rabbit (Weber et al., 2002). It was found that the
NCX had a more important role in Ca2þ removal in rabbits
than in rats, and the ability of the NCX to extrude Ca2þ
Figure 5 Cardiac sarcolemmal NCX protein density in rabbit and rat myocytes (a). Native and NCX immunofluorescent confocal laser
scanning microscope images of the rabbit myocytes (b) and the rat myocytes (c).
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(forward mode) from the ventricular myocytes varied in
different species according to the sequence hamster4guinea
pig4rabbit4ferret4cat4dog4mouse44rat (Bers, 2001).
This suggests that NCX inhibition should cause a greater
increase in the contractile force in the rabbit than in the rat.
However, compensating Ca2þ transport mechanisms may
also have role in the NCX inhibition. The sarcolemmal
Ca2þ -ATPase may adequately compensate for the absent
NCX (Choi and Eisner, 1999a, b). Thus, it is possible that the
greater effect of SEA0400 on the contractility in the rat
reflects the fact that NCX plays a larger role than does the
sarcolemmal Ca2þ -ATPase in Ca2þ extrusion in the rat as
compared with the rabbit. However, previous studies do not
support this hypothesis. The functional sarcolemmal Ca2þ -
ATPase was required beside the NCX to maintain Ca2þ at the
normal low resting level in rat myocytes, and during the
inhibition of NCX more than 70% of the Ca2þ was removed
from the cytoplasm by the sarcolemmal Ca2þ -ATPase (Choi
and Eisner, 1999b). A previous study on rabbit and ferret
myocytes found no effect of the Ca2þ -ATPase inhibitor
carboxyeosin on resting Ca2þ (Bassani et al., 1995). Indirect
ICaL inhibition due to the NCX inhibition is also possible
(Acsai et al., 2007), but no signs of ICaL block was detected.
The inhibitory effect of SEA0400 can be affected by the
level of Nai. The inhibitory potency of SEA0400 was found to
decrease tenfold in response to a fourfold decrease in Nai
(Lee et al., 2004). This indicates that the interspecies
difference in the contractility response to the NCX inhibi-
tion by SEA0400 was due to the different Nai levels. However,
NCX inhibition were almost identical in the rabbit and rat
myocytes when the highest concentration of the SEA0400
was used, but this concentration only increased the con-
tractile force significantly in rats. Thus, clarification of the
exact mechanism of the observed interspecies difference in
the contractility response to NCX inhibition needs further
investigation.
Contractility and NCX protein expression
The NCX protein expression may increase under certain
pathological conditions, such as heart failure or myocardial
hypertrophy (Quinn et al., 2003). The function and protein
expression of the NCX decreases during the development of
the mouse (Reppel et al., 2007). The overexpression of the
NCX in genetically manipulated feline myocytes causes a
decline in contractility (Weisser-Thomas et al., 2005).
Similarly, overexpression of the NCX in rabbit ventricular
myocytes gave rise to a more pronounced decay of the
contraction and a failure to increase the extent of shortening
for the increased frequency of stimulation, which was in
contrast to the findings obtained in the NCX-overexpressing
transgenic mouse (Sipido et al., 2002). The overexpression of
NCX protein by somatic gene transfer in rat myocytes
enhanced both intracellular systolic Ca2þ and contraction
amplitude at low stimulation rates (0.25 Hz), whereas it
reduced cell shortening at higher stimulation frequencies
(42 Hz) (Bo¨lck et al., 2004). The NCX protein expression
levels have not been compared between different species
under physiological conditions. In this study, the NCX
protein densities in the rat and the rabbit were compared to
ascertain whether the different contractility results were
attributable to different levels of NCX protein expression. As
the NCX is widely distributed over the cell surface (Kieval
et al., 1992), immunohistochemistry was performed in
isolated myocytes from rat and rabbit hearts. The fluores-
cence density did not differ between the two species, though
this does not exclude the existence of different NCX
activities despite the similar protein expressions. A decreased
level of phosphorylation of the NCX could lead to a net
reduction of NCX activity in spite of an increased expression
(Quinn et al., 2003). Phosphorylation and the activity of the
NCX were not examined in this study. However, the different
effects of NCX inhibition on contractility in rat and rabbit
hearts cannot be attributed to different levels of NCX
expression in these experiments.
Conclusions
These results indicate that the selective inhibition of the
NCX with SEA0400 increases the contractility in a concen-
tration-dependent manner in the rat isolated heart with a
short action potential duration and a higher intracellular
Naþ concentration, but it does not exert an appreciable
influence on the contractile force in the rabbit isolated heart
with a longer action potential duration and a lower
intracellular Naþ concentration. These data reveal impor-
tant functional interspecies differences in contractility as a
result of NCX inhibition. However, the role of the NCX in
contractility and modulation of the NCX function necessi-
tate further investigations to reveal the exact mechanism of
the observed interspecies difference in the contractility
response to NCX inhibition in rat and rabbit isolated hearts.
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